Diffuse brainstem gliomas in children: Should we or shouldn't we biopsy?

British Journal of Neurosurgery

Volumn 22, Issue 5, 2008, Pages 619-624

  Leach, P A ^a   Estlin, E J ^a   Coope, D J ^b   Thorne, J A ^a   Kamaly Asl, I D ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chemotherapy; Diffuse brainstem glioma; Pontine; Radiotherapy; Stereotactic biopsy

Indexed keywords

6 O BENZYLGUANINE; BETA INTERFERON; CANCER VACCINE; CHOLINE; CILENGITIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; IMATINIB; INTERLEUKIN 13 RECEPTOR; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; N ACETYLASPARTIC ACID; PROTEIN P53; TAMOXIFEN; TEMOZOLOMIDE; THALIDOMIDE; TIPIFARNIB; VASCULOTROPIN;

BRAIN BIOPSY; BRAIN STEM; BRAIN STEM TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; COMBINATION CHEMOTHERAPY; DIAGNOSTIC ACCURACY; DIFFUSE PONTINE GLIOMA; DRUG TARGETING; GLIOMA; HISTOLOGY; HUMAN; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEDIATRIC SURGERY; PONS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEREOTACTIC BIOPSY; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS;

BIOPSY; BRAIN STEM; BRAIN STEM NEOPLASMS; CHILD; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; FAMILY; FEMALE; GLIOMA; HUMANS; MALE; PROGNOSIS; SOCIAL RESPONSIBILITY;

EID: 56549107428     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690802366198     Document Type: Review

References (68)

1. Stroink AR, Harold JH, Hendrick B, et al. Diagnosis and management of pediatric brain-stem gliomas. J Neurosurg 1986;65:745-50.
2. Epstein F, Farmer JP. Brain-stem glioma growth patterns. J Neurosurg 1993;78:408-12.
3. Ternier J, Wray A, Puget S, et al. Tectal plate lesions in children. J Neurosurg 2006(6 Suppl Pediat);104:369-76.
4. Epstein F. A staging system for brain stem gliomas. Cancer 1985;56:1804-6.
5. Jallo GI, Biser-Rohrbaugh A, Freed D. Brainstem gliomas. Child's Nerv Syst 2004;20:143-53.
6. Recinos PF, Sciubba DM, Jallo GI. Brainstem tumours: Where are we today? Pediatr Neurosurg 2007;43:192-201.
7. Berger MS, Edwards MS, LaMasters D, et al. Pediatric brain stem tumours: radiographic, pathological and clinical correlations. Neurosurgery 1983;12:298-302.
8. Littman P, Jarrett P, Bilaniuk LT, et al. Pediatric brain stem gliomas. Cancer 1980;45:2787-92.
9. Allen JC. Brain stem glioma. Neurol Neurosurg Update Ser 4 1983;32:2-7.
10. Albright AL, Guthkelch AN, Packer RJ, et al. Prognostic factors in pediatric brain-stem gliomas. J Neurosurg 1986;65:751-5.
11. Matson DD. Neurosurgery of Infancy and Childhood, 2nd edn. Springfield: Charles C Thomas, 1969.
12. Petronio JA, Edwards MSB. Management of brain stem tumors in children. Contemp Neurosurg 1989;11(7):1-6.
13. Choux M, Lena G, Do L. Brainstem tumors. In: Choux M, Di Rocco C, Hockley A (eds) Pediatric neurosurgery. New York: Churchill Livingstone, 2000:471-91.
14. Albright AL. Brain stem gliomas. In Youmans J (ed.) Neurological surgery. Philadelphia: Saunders, 1996:2603-11.
15. Epstein F, Wisoff JH. Intrinsic brain stem tumors in childhood: surgical indications. J Neurooncol 1988;6:309-17.
16. Milstein JM, Geyer JR, Berger MS, et al. Favourable prognosis for brain stem gliomas in neurofibromatosis. J Neurooncol 1989;7:367-71.
17. Raffel C, McComb JG, Bodner S, et al. Benign brain stem lesions in pediatric patients with neurofibromatosis: case reports. Neurosurgery 1989;25:959-64.
18. Gleason CA, Wise BL, Feinstein B. Stereotactic localisation (with computerized tomographic scanning), biopsy, and radiofrequency treatment of deep brain lesions. Neurosurgery 1978;2:217-22.
19. Artigas J, Ferszt R, Brock M, et al. The relevance of pathological diagnosis for therapy and outcome of brain stem gliomas. Acta Neurochir Suppl (Wien) 1988;42:166-9.
20. Broggi G, Franzini A, Migliavacca F, et al. Stereotactic biopsy of deep tumors in infancy and childhood. Childs Brain 1983;10:92-8.
21. Coffey RJ, Lunsford RD. Diagnosis and treatment of brain stem mass lesions by CT-guided stereotactic surgery. Appl Neurophysiol 1985;48:467-71.
22. Coffey RJ, Lunsford RD. Stereotactic surgery for mass lesions of the midbrain and pons. Neurosurgery 1985;17:12-18.
23. Frank F, Fabrizi AP, Frank-Ricci R, et al. Stereotactic biopsy and treatment of bran stem lesions: combined study of 33 cases (Bologna-Marseille). Acta Neurochir Suppl (Wien) 1988;42:177-81.
24. Franzini A, Allegranza A, Melcarne A, et al. Serial stereotactic biopsy of brain stem expanding lesions. Considerations on 45 consecutive cases. Acta Neurochir Suppl (Wien) 1988;42:170-6.
25. Giunta F, Grasso G, Marini G, et al. Brain stem expanding lesions: stereotactic diagnosis and therapeutic approach. Acta Neurochir Suppl (Wien) 1989;46:86-9.
26. Kratimenos GP, Nouby RM, Bradford R, et al. Image directed stereotactic biopsy for brain stem lesions. Acta Neurochir (Wien) 1992;116:164-70.
27. Thomas DG, Bradford R, Gill S, et al. Computer-directed stereotactic biopsy of intrinsic brain stem lesions. Br J Neurosurg 1988;2:235-40.
28. Epstein F, McCleary EL. Intrinsic brain-stem tumors of childhood: surgical indications. J Neurosurg 1986;64:11-15.
29. Epstein FJ. Letter to the editor: prognosis in pediatric brains-stem gliomas. J Neurosurg 1987;67:323.
30. Albright AL, Guthkelch AN, Packer RJ, et al. Response to: Epstein FJ. Letter to the editor: prognosis in pediatric brains-stem gliomas. J Neurosurg 1987;67:323-4.
31. Albright AL, Packer RJ, Zimmerman R, et al. Magnetic resonance scans should replace biopsies for the diagnosis of brain-stem gliomas: a report from the Children's Cancer Group. Neurosurgery 1993;33:1026-30.
32. Samadani U, Judy KD. Stereotactic brainstem biopsy is indicated for the diagnosis of a vast array of brainstem pathology. Stereo Funct Neurosurg 2003;81:5-9.
33. Schumacher M, Schulte-Monting J, Stoeter P, et al. Magnetic resonance imaging compared with biopsy in the diagnosis of brainstem diseases of childhood: a multicentre review. J Neurosurg (2 Suppl Pediat) 2007;106:111-19.
34. Roujeau T, Machado G, Garnett M, et al. Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg 2007 (1 Suppl Pediat);107:1-4.
35. Korones DN. Treatment of newly diagnosed diffuse brain-stem gliomas in children: in search of the holy grail. Expert Rev Anticancer Ther 2007;7:663-74.
36. Langmoen IA, Lundar T, Storm-Mathisen I, et al. Management of pediatric pontine gliomas. Childs Nerv Syst 1991;7:13-15.
37. Albright AL, Price RA, Guthkelch AN. Brain stem gliomas of children. Cancer 1983;52:2313-19.
38. Packer RJ, Boyett JM, Zimmerman RA, et al. Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Children's Cancer Group Phase I/II trial. Cancer 1993;72:1414-21.
39. Kornreich L, Schwarz M, Karmazyn B, et al. Role of MRI in the management of children with diffuse pontine tumors: a study of 15 patients and review of the literature. Pediat Radiol 2005;35:872-9.
40. Mandell LR, Kadota R, Freeman CR, et al. There is no role for hyperfractionated radiation in the management of children with newly diagnosed diffuse intrinsic brain stem tumors: results of a Pediatric Oncology Group Phase III trial comparing conventional versus hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 1999;43:959-64.
41. Boniscer A, Iacono L, Chintagumpala M, et al. Role of temozolomide after radiotherapy for newly diagnosed diffuse brain stem glioma in children. Cancer 2005;103:133-9.
42. Packer RJ, Prados M, Phillips P, et al. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant B-interferon and hyperfractionated radiotherapy: a Children's Cancer Group Phase I/II study. Cancer 1996;77:2150-6.
43. Broniscer A, Leite CC, Lanchote VL, et al. Radiation therapy and high-dose Tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group. J Clin Oncol 2000;1246-53.
44. Turner CD, Chi S, Marcus KJ, et al. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol 2007;82:95-101.
45. Okada H, Low KL, Kohanbash G, et al. Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas. J Neurooncol 2008;Mar 7 [Epubl ahead of print].
46. Joshi BH, Puri RA, Leland P, et al. Idetification of interleukin-13 receptor α2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. Neuro Oncol 2008;Apr 22 [Epubl ahead of print].
47. Pollack IF, Jakacki RI, Blaney SM, et al. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumour Consortium report. Neuro Oncol 2007;9:145-60. [Epubl 2007 Feb 9].
48. Fouladi M, Nicholson HS, Zhou T, et al. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/ primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer 2007;110:2535-41.
49. Gilbertson RJ, Hill DA, Hernan R, et al. ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res 2003;9:3620-4.
50. Sure U, Reudi D, Tachibana O, et al. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblstomas. J Neuropathol Exp Neurol 1997;56:782-9.
51. Louis DN, Rubio MP, Correa KM, et al. Molecular genetics of pediatric brain stem glioma. Application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol 1993;52:507-15.
52. Cheng Y, Ng HK, Zhang SF, et al. Genetic alterations in pediatric high grade astrocytomas. Hum Pathol 1999;30:1284-90.
53. Sung T, Miller DC, Hayes RL, et al. Preferential inactivation of the p53 suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Brain Path 2000;10:249-59.
54. MacDonald TJ, Stewart CF, Kocak M, et al. Phase I trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012. J Clin Oncol 2008;26:919-24.
55. Broniscer A, Gururangan S, MacDonald TJ, et al. Phase I trial of single dose temozolamide and continuous administration of o6-benzylguanine in children with brain tumors: a Pediatric Brain Tumor Consortium report. Clin Cancer Res 2007;13:6712-8.
56. Kunwar S, Prados MD, Chang SM, et al. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 2007;25:837-44.
57. Kondziolka D, Lundsford LD. Results and expectations with image-integrated brainstem stereotactic biopsy. Surg Neurol 1995;43:558-62.
58. Pincus DW, Richter EO, Yachnis AT, et al. Brainstem stereotactic biopsy sampling in children. J Neurosurg 2006;104(2 Suppl Pediat):108-14.
59. Steck J, Friedman WA. Stereotactic biopsy of brainstem mass lesions. Surg Neurol 1995;43:563-8.
60. Willems JG, Alva-Willems JM. Accuracy of cytological diagnosis of central nervous system neoplasms in stereotactic biopsies. Acta Cytol 1984;28:243-9.
61. Maia AC, Malheiros SM, da Rocha AJ, et al. Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging. J Neurosurg 2004;101:970-6.
62. Sadeghi N, D'Haene N, Decaestecker C, et al. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR 2008;29:476-82.
63. Inoue T, Ogasawara K, Beppu T, et al. Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas. Clin Neurol Neurosurg 2005;107(3):174-80.
64. McKnight TR, Lamborn KR, Love TD, et al. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 2007;106:660-6.
65. Laprie A, Pirzkall A, Haas-Kogan DA, et al. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brain-stem gliomas treated with radiotherapy. Internat J Radiat Oncol Biol Phys 2005;62:20-31.
66. Pirotte BJM, Lubansu A, Massager N, et al. Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors. J Neurosurg: Pediat 2007;107(5):392-9.
67. Kracht LW, Miletic H, Busch S, et al. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 2004;10:7163-70.
68. Poussaint TY, Phillips PC, Vajapeyam S, et al. The Neuroimaging Centre of the Pediatric Brain Tumor Consortium - collaborative neuroimaging in pediatric brain tumor research: a work in progress. AJNR 2007;28:603-7.